SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3iy4'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.15A	1zzrA-3iy4B: undetectable 1zzrB-3iy4B: undetectable	1zzrA-3iy4B: 13.10 1zzrB-3iy4B: 13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.17A	1zzrA-3iy4B: undetectable 1zzrB-3iy4B: undetectable	1zzrA-3iy4B: 13.10 1zzrB-3iy4B: 13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.16A	1zzuA-3iy4B: undetectable 1zzuB-3iy4B: undetectable	1zzuA-3iy4B: 13.10 1zzuB-3iy4B: 13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.14A	1zzuA-3iy4B: undetectable 1zzuB-3iy4B: undetectable	1zzuA-3iy4B: 13.10 1zzuB-3iy4B: 13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.20A	3dqrA-3iy4B: undetectable 3dqrB-3iy4B: undetectable	3dqrA-3iy4B: 13.03 3dqrB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.18A	3dqrA-3iy4B: undetectable 3dqrB-3iy4B: undetectable	3dqrA-3iy4B: 13.03 3dqrB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.15A	3jx2A-3iy4B: undetectable 3jx2B-3iy4B: undetectable	3jx2A-3iy4B: 13.03 3jx2B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.18A	3jx2A-3iy4B: undetectable 3jx2B-3iy4B: undetectable	3jx2A-3iy4B: 13.03 3jx2B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.17A	3jx3A-3iy4B: undetectable 3jx3B-3iy4B: undetectable	3jx3A-3iy4B: 13.03 3jx3B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.18A	3jx3A-3iy4B: undetectable 3jx3B-3iy4B: undetectable	3jx3A-3iy4B: 13.03 3jx3B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 6	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.19A	3jx4A-3iy4B: undetectable 3jx4B-3iy4B: undetectable	3jx4A-3iy4B: 13.03 3jx4B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.21A	3jx4A-3iy4B: undetectable 3jx4B-3iy4B: undetectable	3jx4A-3iy4B: 13.03 3jx4B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.17A	3jx5A-3iy4B: undetectable 3jx5B-3iy4B: undetectable	3jx5A-3iy4B: 13.03 3jx5B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.21A	3jx5A-3iy4B: undetectable 3jx5B-3iy4B: undetectable	3jx5A-3iy4B: 13.03 3jx5B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.19A	3jx6A-3iy4B: undetectable 3jx6B-3iy4B: undetectable	3jx6A-3iy4B: 13.03 3jx6B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.15A	3jx6A-3iy4B: undetectable 3jx6B-3iy4B: undetectable	3jx6A-3iy4B: 13.03 3jx6B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.19A	3nljA-3iy4B: undetectable 3nljB-3iy4B: undetectable	3nljA-3iy4B: 13.03 3nljB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.19A	3nljA-3iy4B: undetectable 3nljB-3iy4B: undetectable	3nljA-3iy4B: 13.03 3nljB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.16A	3nlpA-3iy4B: undetectable 3nlpB-3iy4B: undetectable	3nlpA-3iy4B: 13.03 3nlpB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.19A	3nlpA-3iy4B: undetectable 3nlpB-3iy4B: undetectable	3nlpA-3iy4B: 13.03 3nlpB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 8	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.14A	3nlqA-3iy4B: undetectable 3nlqB-3iy4B: undetectable	3nlqA-3iy4B: 13.03 3nlqB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.21A	3nlqA-3iy4B: undetectable 3nlqB-3iy4B: undetectable	3nlqA-3iy4B: 13.03 3nlqB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.17A	3nlrA-3iy4B: undetectable 3nlrB-3iy4B: undetectable	3nlrA-3iy4B: 13.03 3nlrB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.17A	4cx3A-3iy4B: undetectable 4cx3B-3iy4B: undetectable	4cx3A-3iy4B: 13.03 4cx3B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.16A	4cx3A-3iy4B: undetectable 4cx3B-3iy4B: undetectable	4cx3A-3iy4B: 13.03 4cx3B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.18A	4cx4A-3iy4B: undetectable 4cx4B-3iy4B: undetectable	4cx4A-3iy4B: 13.03 4cx4B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.17A	4cx4A-3iy4B: undetectable 4cx4B-3iy4B: undetectable	4cx4A-3iy4B: 13.03 4cx4B-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4G19_D_ACTD305_0 (GLUTATHIONE TRANSFERASE GTE1)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 4	ILE B 188 LEU B 186 LYS B 124 ASN B 189	None	1.27A	4g19D-3iy4B: undetectable	4g19D-3iy4B: 23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 6	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.18A	5addA-3iy4B: undetectable 5addB-3iy4B: undetectable	5addA-3iy4B: 13.03 5addB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.17A	5addA-3iy4B: undetectable 5addB-3iy4B: undetectable	5addA-3iy4B: 13.03 5addB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 6	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.20A	5adeA-3iy4B: undetectable 5adeB-3iy4B: undetectable	5adeA-3iy4B: 13.03 5adeB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.23A	5adeA-3iy4B: undetectable 5adeB-3iy4B: undetectable	5adeA-3iy4B: 13.03 5adeB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	VAL B 221 ARG B 172 VAL B 123 PHE B 173	None	1.17A	5g0pA-3iy4B: undetectable 5g0pB-3iy4B: undetectable	5g0pA-3iy4B: 13.03 5g0pB-3iy4B: 13.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	3iy4	FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN) (Mus musculus)	4 / 7	PHE B 173 VAL B 221 ARG B 172 VAL B 123	None	1.19A	5g0pA-3iy4B: undetectable 5g0pB-3iy4B: undetectable	5g0pA-3iy4B: 13.03 5g0pB-3iy4B: 13.03

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1ZZR_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.15A","1zzrA-3iy4B:undetectable;1zzrB-3iy4B:undetectable","1zzrA-3iy4B:13.10;1zzrB-3iy4B:13.10"],["1ZZR_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.17A","1zzrA-3iy4B:undetectable;1zzrB-3iy4B:undetectable","1zzrA-3iy4B:13.10;1zzrB-3iy4B:13.10"],["1ZZU_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.16A","1zzuA-3iy4B:undetectable;1zzuB-3iy4B:undetectable","1zzuA-3iy4B:13.10;1zzuB-3iy4B:13.10"],["1ZZU_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.14A","1zzuA-3iy4B:undetectable;1zzuB-3iy4B:undetectable","1zzuA-3iy4B:13.10;1zzuB-3iy4B:13.10"],["3DQR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.20A","3dqrA-3iy4B:undetectable;3dqrB-3iy4B:undetectable","3dqrA-3iy4B:13.03;3dqrB-3iy4B:13.03"],["3DQR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.18A","3dqrA-3iy4B:undetectable;3dqrB-3iy4B:undetectable","3dqrA-3iy4B:13.03;3dqrB-3iy4B:13.03"],["3JX2_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.15A","3jx2A-3iy4B:undetectable;3jx2B-3iy4B:undetectable","3jx2A-3iy4B:13.03;3jx2B-3iy4B:13.03"],["3JX2_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.18A","3jx2A-3iy4B:undetectable;3jx2B-3iy4B:undetectable","3jx2A-3iy4B:13.03;3jx2B-3iy4B:13.03"],["3JX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.17A","3jx3A-3iy4B:undetectable;3jx3B-3iy4B:undetectable","3jx3A-3iy4B:13.03;3jx3B-3iy4B:13.03"],["3JX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.18A","3jx3A-3iy4B:undetectable;3jx3B-3iy4B:undetectable","3jx3A-3iy4B:13.03;3jx3B-3iy4B:13.03"],["3JX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.19A","3jx4A-3iy4B:undetectable;3jx4B-3iy4B:undetectable","3jx4A-3iy4B:13.03;3jx4B-3iy4B:13.03"],["3JX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.21A","3jx4A-3iy4B:undetectable;3jx4B-3iy4B:undetectable","3jx4A-3iy4B:13.03;3jx4B-3iy4B:13.03"],["3JX5_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.17A","3jx5A-3iy4B:undetectable;3jx5B-3iy4B:undetectable","3jx5A-3iy4B:13.03;3jx5B-3iy4B:13.03"],["3JX5_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.21A","3jx5A-3iy4B:undetectable;3jx5B-3iy4B:undetectable","3jx5A-3iy4B:13.03;3jx5B-3iy4B:13.03"],["3JX6_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.19A","3jx6A-3iy4B:undetectable;3jx6B-3iy4B:undetectable","3jx6A-3iy4B:13.03;3jx6B-3iy4B:13.03"],["3JX6_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.15A","3jx6A-3iy4B:undetectable;3jx6B-3iy4B:undetectable","3jx6A-3iy4B:13.03;3jx6B-3iy4B:13.03"],["3NLJ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.19A","3nljA-3iy4B:undetectable;3nljB-3iy4B:undetectable","3nljA-3iy4B:13.03;3nljB-3iy4B:13.03"],["3NLJ_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.19A","3nljA-3iy4B:undetectable;3nljB-3iy4B:undetectable","3nljA-3iy4B:13.03;3nljB-3iy4B:13.03"],["3NLP_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.16A","3nlpA-3iy4B:undetectable;3nlpB-3iy4B:undetectable","3nlpA-3iy4B:13.03;3nlpB-3iy4B:13.03"],["3NLP_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.19A","3nlpA-3iy4B:undetectable;3nlpB-3iy4B:undetectable","3nlpA-3iy4B:13.03;3nlpB-3iy4B:13.03"],["3NLQ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.14A","3nlqA-3iy4B:undetectable;3nlqB-3iy4B:undetectable","3nlqA-3iy4B:13.03;3nlqB-3iy4B:13.03"],["3NLQ_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.21A","3nlqA-3iy4B:undetectable;3nlqB-3iy4B:undetectable","3nlqA-3iy4B:13.03;3nlqB-3iy4B:13.03"],["3NLR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.17A","3nlrA-3iy4B:undetectable;3nlrB-3iy4B:undetectable","3nlrA-3iy4B:13.03;3nlrB-3iy4B:13.03"],["4CX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.17A","4cx3A-3iy4B:undetectable;4cx3B-3iy4B:undetectable","4cx3A-3iy4B:13.03;4cx3B-3iy4B:13.03"],["4CX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.16A","4cx3A-3iy4B:undetectable;4cx3B-3iy4B:undetectable","4cx3A-3iy4B:13.03;4cx3B-3iy4B:13.03"],["4CX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.18A","4cx4A-3iy4B:undetectable;4cx4B-3iy4B:undetectable","4cx4A-3iy4B:13.03;4cx4B-3iy4B:13.03"],["4CX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.17A","4cx4A-3iy4B:undetectable;4cx4B-3iy4B:undetectable","4cx4A-3iy4B:13.03;4cx4B-3iy4B:13.03"],["4G19_D_ACTD305_0","GLUTATHIONE TRANSFERASE GTE1","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"ILE B 188;LEU B 186;LYS B 124;ASN B 189","None","1.27A","4g19D-3iy4B:undetectable","4g19D-3iy4B:23.19"],["5ADD_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.18A","5addA-3iy4B:undetectable;5addB-3iy4B:undetectable","5addA-3iy4B:13.03;5addB-3iy4B:13.03"],["5ADD_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.17A","5addA-3iy4B:undetectable;5addB-3iy4B:undetectable","5addA-3iy4B:13.03;5addB-3iy4B:13.03"],["5ADE_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.20A","5adeA-3iy4B:undetectable;5adeB-3iy4B:undetectable","5adeA-3iy4B:13.03;5adeB-3iy4B:13.03"],["5ADE_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.23A","5adeA-3iy4B:undetectable;5adeB-3iy4B:undetectable","5adeA-3iy4B:13.03;5adeB-3iy4B:13.03"],["5G0P_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"VAL B 221;ARG B 172;VAL B 123;PHE B 173","None","1.17A","5g0pA-3iy4B:undetectable;5g0pB-3iy4B:undetectable","5g0pA-3iy4B:13.03;5g0pB-3iy4B:13.03"],["5G0P_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","3iy4","FRAGMENT OF NEUTRALIZING ANTIBODY 15 (HEAVY CHAIN)","Mus musculus",4,"PHE B 173;VAL B 221;ARG B 172;VAL B 123","None","1.19A","5g0pA-3iy4B:undetectable;5g0pB-3iy4B:undetectable","5g0pA-3iy4B:13.03;5g0pB-3iy4B:13.03"]]